Can This High-Yield Dividend Stock Keep Beating the S&P 500?
Dividend stocks are potent instruments for building wealth. A staggering 85% of the S 500's total returns since 1960 have emanated from dividend payouts, according to a report by Hartford Funds.
Amgen (NASDAQ: AMGN), a top-tier U.S. biotech firm, has been a coveted dividend stock since it began regular distributions to shareholders in 2011. Highlighting this fact, the company's shares have significantly outperformed the S 500 during this time.
Source Fool.com
Amgen Inc. Aktie
289,10 €
-1,15 %
Starke Kaufsignale für Amgen Inc.: Keine Sell-Einschätzungen, nur Buy-Einschätzungen.
Für Amgen Inc. ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 304 € im Vergleich zu 289.1 €.
